Dogs are man's best friend: in sickness and in health.
With the median survival of 14.6 months following best available standard of care, malignant gliomas (MGs) remain one of the biggest therapeutic challenges of the modern time. Although the last several decades have witnessed tremendous advancement in our understanding of MG and evolution of many successful preclinical therapeutic strategies, even the most successful preclinical therapeutic strategies often fail to cross the phase I/II clinical trial threshold. One of the significant, but less commonly discussed, barriers in developing effective glioma therapy is the lack of a robust preclinical model. For the last 30 years, rodent orthotopic xenograft models have been extensively used in the preclinical setting. Although they provide a good basic model for understanding tumor biology, their value in successfully translating preclinical therapeutic triumph into clinical success is extremely poor. Companion dogs, which share the same environmental stress as their human counterparts, also spontaneously develop MGs. Dog gliomas that develop spontaneously in an immunocompetent host are very similar to human gliomas and potentially provide a stronger platform for validating the efficacy of therapeutic strategies proven successful in preclinical mouse models. Integrating this model can accelerate development of effective therapeutic options that will benefit both human subjects and pet dogs.
Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, Indiana, USA.
R Timothy
RT
Bentley
Northwestern University, Chicago, Illinois, USA.
Atique U
AU
Ahmed
Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, Indiana, USA.
Amy B
AB
Yanke
Department of Neurosurgery, Indiana University, Indianapolis, Indiana, USA.
Aaron A
AA
Cohen-Gadol
Department of Neurosurgery, Indiana University, Indianapolis, Indiana, USA.
Mahua
M
Dey
D000818:Animals; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D004195:Disease Models, Animal; D004285:Dogs; D005910:Glioma / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans
canine glioma; comparative oncology; glioblastoma; malignant glioma; spontaneous glioma